the observation leads to the conclusion that cyclophosphamide therapy should not be used in view of absence of favourable effect on the course of multiple sclerosis and the risk of increased frequency of malignant neoplasms which can not be ruled out in this method .
C0010583
cyclophosphamide
C0026769
multiple sclerosis